Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.69 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.68 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | GAA | P10253 | 4/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | MGAM | O43451 | 1/20 | 0.54 |
| ▸ | RHOA | P61586 | 3/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.52 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.52 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL372256 | 1.00 | RAB9A (1.00) | RAB9AKDM4EKMT2ASMN1; SMN2PDGFRB | |
| SCHEMBL17461333 | 1.00 | RAB9A (1.00) | RAB9AKDM4EKMT2ASMN1; SMN2PDGFRB | |
| Hydrochloric Acid SCHEMBL6788092 | 0.98 | RAB9A (0.97) | RAB9AKDM4EKMT2ASMN1; SMN2PDGFRB | |
| Hydrochloric Acid SCHEMBL7262691 | 0.98 | RAB9A (0.97) | RAB9AKDM4EKMT2ASMN1; SMN2PDGFRB | |
| SCHEMBL6782723 | 0.89 | RAB9A (0.81) | RAB9AKDM4EKMT2ASMN1; SMN2PDGFRB | |
| SCHEMBL6421753 | 0.86 | RAB9A (0.75) | RAB9AKDM4EKMT2ASMN1; SMN2PDGFRB | |
| SCHEMBL4936531 | 0.86 | RAB9A (0.75) | RAB9AKDM4EKMT2ASMN1; SMN2PDGFRB | |
| SCHEMBL6421749 | 0.86 | RAB9A (0.75) | RAB9AKDM4EKMT2ASMN1; SMN2PDGFRB | |
| SCHEMBL5717723 | 0.86 | RAB9A (0.75) | RAB9AKDM4EKMT2ASMN1; SMN2PDGFRB | |
| SCHEMBL8966515 | 0.86 | RAB9A (0.75) | RAB9AKDM4EKMT2ASMN1; SMN2PDGFRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1268347-B1 | PALLADIUM COMPLEX SALT AND USE THEREOF FOR ADJUSTING PALLADIUM CONCENTRATION OF AN ELECTROLYTIC SOLUTION FOR DEPOSIT OF PALLADIUM OR ONE OF ITS ALLOYS | ENGELHARD CLAL SAS (FR) | 2005-06-29 | — | — | EP | claimed |
| EP-1423557-B1 | ELECTROLYTIC SOLUTION FOR ELECTROCHEMICAL DEPOSITION OF GOLD AND ITS ALLOYS | METALOR TECHNOLOGIES FRANCE S (FR) | 2004-12-22 | — | — | EP | claimed |
| US-6743950-B2 | For use in electrical contacts and the connectors used in the field of electronics receive, as a finish, thin layers of electroplated precious metals having brightness, ductility, non-porous and have corrosion resistance | METALOR TECHNOLOGIES FRANCE SAS (FR) | 2004-06-01 | — | — | US | claimed |
| US-6743346-B2 | AQUEOUS ACIDIC ELECTROLYSIS BATH INCLUDING PALLADIUM COMPOUND, OPTIONAL COMPOUND OF SECONDARY METAL, ETHYLENEDIAMINE AS PALLADIUM COMPLEXING AGENT, AND 3-(3-PYRIDYL)ACRYLIC ACID, 3-(3-QUINOLYL)ACRYLIC ACID OR SALT AS ORGANIC BRIGHTENER | METALOR TECHNOLOGIES FRANCE SAS A FRENCH SIMPLIFIED JOINT STOCK COMPANY (FR) | 2004-06-01 | — | — | US | claimed |
| EP-1272691-B1 | ELECTROLYTIC SOLUTION FOR ELECTROCHEMICAL DEPOSIT OF PALLADIUM OR ITS ALLOYS | METALOR TECHNOLOGIES FRANCE S (FR) | 2004-03-17 | — | — | EP | claimed |
| US-20030183533-A1 | Electrolytic solution for electrochemical deposit of palladium or its alloys | METALOR TECHNOLOGIES FRANCE SAS A FRENCH SIMPLIFIED JOINT STOCK COMPANY (FR) | 2003-10-02 | — | — | US | claimed |
| US-20030047460-A1 | Palladium complex salt and use thereof for adjusting palladium concentration of an electrolytic solution for deposit of palladium or one of its alloys | METALOR TECHNOLOGIES FRANCE SAS A FRENCH SIMPLIFIED JOINT STOCK COMPANY (FR) | 2003-03-13 | — | — | US | claimed |
| EP-3538526-B1 | CYCLOBUTANE- AND AZETIDINE-CONTAINING MONO AND SPIROCYCLIC COMPOUNDS AS ALPHA V INTEGRIN INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2024-04-10 | — | — | EP | disclosed |
| US-11639353-B2 | Cyclobutanes- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-05-02 | — | — | US | disclosed |
| US-11485725-B2 | Derivatives of piperlongumine and uses thereof | AURANSA INC. (US) | 2022-11-01 | — | — | US | disclosed |
| US-20210246136-A1 | CYCLOBUTANES- AND AZETIDINE-CONTAINING MONO AND SPIROCYCLIC COMPOUNDS AS ALPHA V INTEGRIN INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2021-08-12 | — | — | US | disclosed |
| US-20210198235-A1 | DERIVATIVES OF PIPERLONGUMINE AND USES THEREOF | AURANSA INC. | 2021-07-01 | — | — | US | disclosed |
| US-20210198235-A1 | DERIVATIVES OF PIPERLONGUMINE AND USES THEREOF | AURANSA INC. | 2021-07-01 | — | — | US | disclosed |
| EP-0974584-A1 | FUSED RING COMPOUNDS, PROCESS FOR PRODUCING THE SAME AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2000-01-26 | — | — | EP | disclosed |
| US-5994368-A | ANTIALLERGENS, ANTIINFLAMMATORY AGENTS, ANALGESICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-11-30 | — | — | US | disclosed |
| EP-0807105-A1 | PYRIDOPYRIMIDONES, QUINOLINES AND FUSED N-HERETOCYCLES AS BRADYKININ ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-11-19 | — | — | EP | disclosed |
| WO-1996013485-A1 | PYRIDOPYRIMIDONES, QUINOLINES AND FUSED N-HERETOCYCLES AS BRADYKININ ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-05-09 | — | — | WO | disclosed |
| US-4767507-A | 3-(3-PYRIDYL) ACRYLIC ACID AND 3-(3-QUINOLYL) ACRYLIC ACID ADDITIVES; CORROSION AND WEAR RESISTANCE | ENGELHARD CORPORATION (US) | 1988-08-30 | — | — | US | disclosed |
| US-4216318-A | HISTAMINE HZ-ANTAGONISTS, ISOCYTOSINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1980-08-05 | — | — | US | disclosed |
| US-4154834-A | HETEROCYCLIC-(THIO)ALKYLAMINO SUBSTITUTED-4-PYRIMIDONE OR -THIONES | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1979-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210246136-A1 | CYCLOBUTANES- AND AZETIDINE-CONTAINING MONO AND SPIROCYCLIC COMPOUNDS AS ALPHA V INTEGRIN INHIBITORS | ITGB1, ITGAV, ITGA1 | RAB9A 301/4885KDM4E 1994/4885KMT2A 3761/4885 |
| US-11639353-B2 | Cyclobutanes- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors | ITGB1, ITGB2, ITGA1 | RAB9A 329/4885KDM4E 2185/4885KMT2A 3748/4885 |
| US-20210198235-A1 | DERIVATIVES OF PIPERLONGUMINE AND USES THEREOF | THPO, PIR, PAK6 | RAB9A 1941/4885KDM4E 636/4885KMT2A 2507/4885 |
| US-11485725-B2 | Derivatives of piperlongumine and uses thereof | PIR, THPO, DHPS | RAB9A 1731/4885KDM4E 635/4885KMT2A 2612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.